Nurse Practitioner in Inman, SC Accepting Medicare
9 Nurse Practitioner nurses found. Showing 1 - 9
 Kishimjan Beishenalievna Ketner, NP Nurse Practitioner - Primary Care Medicare: Accepting Medicare Assignments Practice Location: 150 Holly Springs Church Rd, Inman, SC 29349 Phone: 864-921-4479 Fax: 864-734-4887 |
Mrs. Sherry Foster Eison, APRN, FNP-BC Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 368 Garnet Valley Dr, Inman, SC 29349 Phone: 864-208-4726 |
Mrs. Lakeisha Kierra Turner, FNP-C Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 304 S Ivestor Ct, Inman, SC 29349 Phone: 803-673-2848 |
Mrs. Amber Christine Flynn, APRN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 12230 Asheville Hwy, Inman, SC 29349 Phone: 864-472-2144 |
Victoria Michelle Cochran, Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 3 Harris St, Inman, SC 29349 Phone: 864-360-1699 |
Mrs. Shela Beth Hipolito, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1827, 59 Blackstock Rd, Inman, SC 29349 Phone: 864-472-2028 |
Mrs. Christina R Cook, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 63 Blackstock Rd, Inman, SC 29349 Phone: 337-991-9276 |
Mrs. Melissa Blair Kimbrell, FNP-BC Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 575 Ingles Dr, Inman, SC 29349 Phone: 864-342-4090 Fax: 864-578-7098 |
Louise W Swindler, APRN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 718 Midnight Rd, Inman, SC 29349 Phone: 864-431-5886 |
News Archive
Lapatinib-pazopanib combination therapy not beneficial for patients with inflammatory breast cancer
Inflammatory breast cancer is a very aggressive type of cancer associated with early metastasis and poor survival rates, and the prognosis is even worse for patients with tumors expressing the ErbB2 receptor. The ErbB2-inhibiting drug lapatinib can slow the spread of cancer cells in individuals with advanced breast cancer who have already tried other chemotherapy medications.
OICR makes equity investments in three promising Ontario technologies
Frank Stonebanks, Vice-President, Commercialization and Chief Commercial Officer of the Ontario Institute for Cancer Research today announced that OICR has made equity investments in three promising Ontario technologies to accelerate their commercialization.
New statistics show oesophageal cancer rates increase by 50% in men
Oesophageal cancer rates in men have increased by 50 per cent since the early 1980s, with new cases reaching almost 6,000, according to new statistics from Cancer Research UK.
Truven Health Analytics announces acquisition of Fortel Analytics' healthcare fraud technology
Truven Health Analytics, a leading provider of healthcare analytics and data solutions and services, today announced the acquisition of Fortel Analytics' healthcare fraud technology. The acquisition gives Truven Health exclusive access to a breakthrough suite of predictive solutions, analysis methods and analytic technology designed to quickly identify suspicious patterns in healthcare insurance claims data before claims are ever paid.
› Verified 1 days ago